Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
MASIMO CORP (MASI) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MASI at 55.9/100 on a 32-signal composite quality model, placing it at rank #1,217 of 2,960 stocks — the top half of the AI-ranked universe. MASI scores in the top quartile across earnings quality (90.2). Areas of concern include institutional flow (0.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 37.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), MASIMO CORP reports quarterly revenue of $403.6M, net income of $57.1M, an operating margin of 19.2%. Top institutional holders of MASI by reported 13-F value include BlackRock, Politan Capital Management, Pentwater Capital Management, based on the most recent SEC filings. MASI trades on the Nasdaq exchange and files with the SEC under CIK 937556. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MASI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MASIMO CORP directly from SEC EDGAR.
AI Quality Score
55.9/100
AI Rank
#1,217
Revenue
$403.6M
Net Income
$57.1M
Free Cash Flow
$41.0M
Operating Margin
19.2%
| Period | Form | Revenue | Net income | Operating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $1.5B | $-151.5M | 20.3% |
| FY 2024 | 10-K | $1.4B | $-304.9M | 4.5% |
| FY 2023 | 10-K | $1.3B | $81.5M | 13.0% |
| FY 2022 | 10-K | $2.0B | $143.5M | 10.3% |
| FY 2021 | 10-K | $1.2B | $229.6M | 22.3% |
| FY 2020 | 10-K | $1.1B | $240.3M | 22.4% |
| Institution | Shares | Value | Reported |
|---|---|---|---|
| BlackRock | 4,644,578 | $826.1M | 2026-03-31 |
| Politan Capital Management | 4,589,648 | $816.4M | 2026-03-31 |
| Pentwater Capital Management | 3,176,000 | $564.9M | 2026-03-31 |
| BARCLAYS PLC | 2,743,985 | $488.1M | 2026-03-31 |
| HBK INVESTMENTS L P | 2,576,109 | $458.2M | 2026-03-31 |
| MASSACHUSETTS FINANCIAL SERVICES | 2,342,790 | $416.7M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT | 2,050,045 | $364.6M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT | 2,006,861 | $357.0M | 2026-03-31 |
| FMR | 1,450,823 | $258.1M | 2026-03-31 |
| STATE STREET | 1,437,724 | $255.7M | 2026-03-31 |
13F Pro Quality Score
Rank #1,217 of 2,960 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk